The release of Molnovir & Vorasan | Sana Pharma
The release of Molnovir & Vorasan
Home » SANA Pharma News » The release of Molnovir & Vorasan
Saturday, September 17, 2022

Sana Pharma proudly announces the release of two new medications in the Jordanian market. Vorasan, Vortioxetine, the first and only antidepressant that improves cognitive function associated with daily functioning at work, home and socially, and it has been found to be the most effective and best-tolerated option for major depressive disorder (MDD).

Molnovir, Molnupiravir, the first oral, FDA-Approved, direct acting anti viral drug for the treatment of mild to moderate covid-19 disease.